CurrentEndo
Get Weekly

CurrentEndo coverage · page 3 of 3

Nature Medicine

Briefs 81–100 of 100 CurrentEndo has covered from this journal, newest publication first

Latest from Nature Medicine

All coverage, newest first

  1. Nat Med

    Association of semaglutide with risk of suicidal ideation in a real-world cohort

    Cohort studyObesity

  2. Nat Med

    A deep learning system for predicting time to progression of diabetic retinopathy

    Diagnostic or prognostic studyComplications

  3. Nat Med

    Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

    Meta-analysisT2D & other

  4. Nat Med

    Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial

    Randomized controlled trialObesity

  5. Nat Med

    Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine

    Guideline or statementT2D & other

  6. Nat Med

    Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial

    Randomized controlled trialT1D

  7. Nat Med

    Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial

    Randomized controlled trial

  8. Nat Med

    Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial

    Secondary analysisObesity

  9. Nat Med

    Penetrance of pathogenic genetic variants associated with premature ovarian insufficiency

    Research articleReproductive endocrine

  10. Nat Med

    Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial

    Randomized controlled trialT2D & other

  11. Nat Med

    Accelerated waning of the humoral response to COVID-19 vaccines in obesity

    Cohort studyObesity

  12. Nat Med

    Incident type 2 diabetes attributable to suboptimal diet in 184 countries

    Research articleT2D & other

  13. Nat Med

    Intermittent fasting plus early time-restricted eating versus calorie restriction and standard care in adults at risk of type 2 diabetes: a randomized controlled trial

    Randomized controlled trialT2D & other

  14. Nat Med

    Multiomic signatures of body mass index identify heterogeneous health phenotypes and responses to a lifestyle intervention

    Cohort studyObesity

  15. Nat Med

    Optimal dietary patterns for prevention of chronic disease

    Cohort studyT2D & other

  16. Nat Med

    Landscape of pathogenic mutations in premature ovarian insufficiency

    Case-control studyReproductive endocrine

  17. Nat Med

    [11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial

    Diagnostic or prognostic studyAdrenal

  18. Nat Med

    Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial

    Randomized controlled trialTechnology

  19. Nat Med

    Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study

    Secondary analysisT2D & other

  20. Nat Med

    Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study

    Randomized controlled trialT2D & other

All 100 Briefs in ExploreShowing Briefs 81–100 of 100, newest first